AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3935869
Drug: Buserelin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (2 X 1 mg subcutaneously after parenteral treatment with 3 mg per day in the first week)
Trial: 3935869
Drug: Buserelin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (3 X 400 micrograms intranasally) + Tamoxifen (2 X 20 mg)
Trial: 3935869
Drug: Buserelin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (3 X 400 micrograms intranasally) + Megestrol acetate (4 X 45 mg)
Trial: 27080498
Drug: Rituximab (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (375 mg/m² on day 1 and day 6 during the first two courses of chemotherapy) plus chemotherapy (lymphome malin B [LMB])
Trial: 27080498
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (no rituximab)
Trial: 17611322
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with midazolam (Group A and B: 16-25 mg/10s; Group C and D: 6-7 mg/10s)
Trial: 10597550
Drug: Propofol 3
RxNorm normalized name: fospropofol 35 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3 mg.kg‐1 followed by a maintenance infusion of 5 mg.kg‐1.h‐1
Trial: 8567345
Drug: Preoperative concomitant
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative concomitant radiochemotherapy (two courses of 18.5 Gy in five fractions, continuous infusion of 5-FU 800 mg/m2 days 1-5 and cisplatinum 70 mg/m2 day 2)
Trial: 1824249
Drug: Cytarabine (Ara‐C)
RxNorm normalized name: Cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cytarabine (Ara‐C) 100 mg/m2 (A100)
Trial: 1824249
Drug: Cytarabine (Ara‐C)
RxNorm normalized name: Cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cytarabine (Ara‐C) 200 mg/m2 (A200)
Trial: 29525617
Drug: Oral acetazolamide
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acetazolamide administered 1 hour preoperatively
Trial: 29525617
Drug: Oral acetazolamide
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acetazolamide administered 3 hours postoperatively
Trial: 29525617
Drug: No administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No administration of acetazolamide
Trial: 26340097
Drug: Oral solifenacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral solifenacin succinate 5 mg/day
Trial: 24196466
Drug: Topical (intra-articular)
RxNorm normalized name: Topicale
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical (intra-articular) tranexamic acid
Trial: 16481638
Drug: High-dose adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose adjuvant interferon alfa-2b
Trial: 15215813
Drug: Rosuvastatin 5
RxNorm normalized name: rosuvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 5 mg and 10 mg
Trial: 15215813
Drug: Rosuvastatin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (all doses)
Trial: 10974371
Drug: Combination antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination antiretroviral treatment
Trial: 30534008
Drug: Rivaroxaban 10
RxNorm normalized name: rivaroxaban 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 10 mg
Trial: 22595363
Drug: Galantamine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (8 mg/day for 4 weeks, then 16 mg/day for 12 weeks)
Trial: 20704493
Drug: dTpa vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dTpa vaccine
Trial: 25424783
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A control vaccine
Trial: 12413615
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of mifepristone alone (Group 1)
Trial: 12413615
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of tamoxifen with 10 mg of mifepristone (Group 2)
Trial: 9042043
Drug: Budesonide via
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide via Turbuhaler (0.4, 0.8, 1.6, and 2.4 mg/day for 2 weeks)
Trial: 7930659
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of aspirin per day
Trial: 31350828
Drug: Early intensive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intensive antihypertensive treatment (100 mg urapidil and 30 mL of 0.9% sodium chloride after initial 25 mg urapidil injection)
Trial: 31350828
Drug: Early intensive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intensive antihypertensive treatment
Trial: 31350828
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (25 mg urapidil injection)
Trial: 29322620
Drug: Spent hops-rice
RxNorm normalized name: HOPS
DrugBank: Hops (DB10687)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spent hops-rice protein matrix preparation
Trial: 29322620
Drug: Control spent
RxNorm normalized name: spelt seed extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control spent hops preparation
Trial: 26597151
Drug: Low-dose lipopolysaccharide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose lipopolysaccharide (LPS) 0.4 ng/kg
Trial: 30682067
Drug: Treatment‐as‐usual (TAU)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment‐as‐usual (TAU)
Trial: 21156883
Drug: Insulin initiation
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin initiation
Trial: 21156883
Drug: Concomitant use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant use of oral antihyperglycemic agents
Trial: 17389205
Drug: Topical papaverine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical papaverine application at room temperature
Trial: 17389205
Drug: Topical heated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical heated papaverine (at 37 degrees C) application
Trial: 17389205
Drug: Pedicle storage
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pedicle storage in normothermic conditions combined with topical papaverine application
Trial: 17389205
Drug: Pedicle storage
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pedicle storage in normothermic conditions combined with topical heated papaverine application
Trial: 17389205
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment, stored at room temperature)
Trial: 15647189
Drug: Synbiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotic therapy (Bifidobacterium longum/Synergy 1)
Trial: 12374247
Drug: Oral bisphosphonates
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bisphosphonates
Trial: 24311451
Drug: Big breakfast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Big breakfast (BB) rich in fat and protein providing 33% of total daily energy
Trial: 24311451
Drug: Small breakfast
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small breakfast (SB) rich in carbohydrates providing 12.5% of total daily energy
Trial: 22445437
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing levonorgestrel and EE
Trial: 14969377
Drug: Listerine Oral
RxNorm normalized name: Listerine Oral Liquid Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Listerine Oral Care Strip
Trial: 14969377
Drug: Saturated Saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saturated Saline Solution
Trial: 11159485
Drug: Standard method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard method of performing the TFI with and without topical anaesthetic
Trial: 2905879
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 mg twice daily
Trial: 2905879
Drug: Bopindolol 1
RxNorm normalized name: bopindolol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bopindolol 1 mg daily
Trial: 26315876
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (50 mg/kg)
Trial: 26315876
Drug: Control (rocuronium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (rocuronium 0.6 mg/kg)
Trial: 26315876
Drug: Rocuronium prime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium prime (0.06 mg/kg rocuronium 3 minutes before 0.54 mg/kg rocuronium)
Trial: 26315876
Drug: Rocuronium 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.9 (0.9 mg/kg)
Trial: 21241263
Drug: No oxytocic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oxytocic agent (control group)
Trial: 18278988
Drug: Acute bilateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute bilateral electroconvulsive therapy (ECT)
Trial: 17103080
Drug: Hempseed oil
RxNorm normalized name: OPHIOCORDYCEPS SINENSIS 0.1 g ORAL CAPSULE [HempSeed Cordyceps]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hempseed oil (HO) 30 ml/day for 4 weeks
Trial: 17103080
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (FO) 30 ml/day for 4 weeks
Trial: 12924534
Drug: Nebulized zanamivir
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Nebulized zanamivir (16 mg four times a day) plus rimantadine
Trial: 11070372
Drug: sipatrigine (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sipatrigine (10, 18, 27, or 36 mg/kg by continuous intravenous infusion over 65 hours)
Trial: 8622153
Drug: AVS (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVS (4 g, infused intravenously for 6-8 hours once a day for 10 to 14 days)
Trial: 8622153
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 g glucose, infused intravenously for 6-8 hours once a day for 10 to 14 days)
Trial: 1567268
Drug: Gentian violet
RxNorm normalized name: Gentian Violet
DrugBank: Gentian violet cation (DB00406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gentian violet mouth washes (1.5 ml 0.5% aqueous solution b.i.d.)
Trial: 1567268
Drug: Oral ketoconazole
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ketoconazole (200 mg/day, after a meal)
Trial: 1567268
Drug: Nystatin mouth
RxNorm normalized name: DIPHEN/LIDOCAINE/NYSTATIN MOUTHWASH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nystatin mouth washes (200,000 U oral suspension q.i.d.)
Trial: 24438754
Drug: Iron supplement
RxNorm normalized name: Iron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplement of 40 mg/d
Trial: 24438754
Drug: Iron supplement
RxNorm normalized name: Iron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplement of 80 mg/d
Trial: 24438754
Drug: Iron supplement
RxNorm normalized name: Iron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplement of 20 mg/d
Trial: 24438754
Drug: Iron supplement
RxNorm normalized name: Iron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplement of 40 mg/d (Stratum #1)
Trial: 24438754
Drug: Iron supplement
RxNorm normalized name: Iron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplement of 40 mg/d (Stratum #2)
Trial: 22710812
Drug: Intraoperative infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative infusion of 18 compound amino acids (group AA)
Trial: 22710812
Drug: Lactated Ringer
RxNorm normalized name: lactated ringers
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer solution (group LR)
Trial: 19436119
Drug: IVIG 2
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG 2 g/kg for 1 day
Trial: 19436119
Drug: IVIG 1
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG 1 g/kg for 1 day
Trial: 19436119
Drug: IVIG 400
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG 400 mg/kg/day for 5 days
Trial: 19436119
Drug: No IVIG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No IVIG administration
Trial: 11923801
Drug: Azimilide 125
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 125 mg
Trial: 8771231
Drug: Cortisol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol (3 mg/h)
Trial: 2170104
Drug: Instant bean
RxNorm normalized name: Bean
DrugBank: Bean (DB14709)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instant bean flakes (40 g starch)
Trial: 2170104
Drug: Potato flakes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potato flakes (40 g starch)
Trial: 6389484
Drug: Controlled-release theophylline
RxNorm normalized name: theophylline Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release theophylline preparation U (Uniphyl tablets) once daily, 800 mg
Trial: 6389484
Drug: Controlled-release theophylline
RxNorm normalized name: theophylline Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release theophylline T-D (Theo-Dur tablets) administered 12-hourly, 800 mg
Trial: 30303904
Drug: IV sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV sedation (100 micrograms fentanyl and 2 mg midazolam)
Trial: 26783318
Drug: Intravenous rt-PA
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous rt-PA (alteplase)
Trial: 25303029
Drug: Capsules containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules containing VFB
Trial: 22760386
Drug: 3M DuraPrep
RxNorm normalized name: Iodine Povacrylex 6.02 mg in 1 mL / Isopropyl Alcohol 636.4 mg in 1 mL TOPICAL SOLUTION [3M DuraPrep Surgical]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3M DuraPrep Surgical Solution Patient Preoperative Skin Preparation
Trial: 22760386
Drug: ChloraPrep with
RxNorm normalized name: ChloraPrep
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ChloraPrep with Tint (Scrub Teal) Patient Preoperative Skin Preparation
Trial: 17914062
Drug: MK-0974 300
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0974 300 mg
Trial: 17914062
Drug: MK-0974 400
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0974 400 mg
Trial: 17914062
Drug: MK-0974 600
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0974 600 mg
Trial: 9385350
Drug: Low-dose cladribine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cladribine (2‐CdA) at a dosage of 0.05 mg/kg subcutaneously weekly for 8 weeks
Trial: 2975949
Drug: Warfarin (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (n = 56)
Trial: 29735215
Drug: MMF dispersible
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF dispersible tablets (MMFdt)
Trial: 29735215
Drug: MMF capsules
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF capsules (MMFc)
Trial: 22278741
Drug: simvastatin alone
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: simvastatin alone (40 mg/day)
Trial: 22278741
Drug: ezetimibe/simvastatin combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe/simvastatin combined therapy (10/20 or 10/40 mg/day)
Trial: 25534866
Drug: ezetimibe/simvastatin 10/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe/simvastatin 10/40 mg/day
Trial: 17635889
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (n = 1537) received a telephone counseling program with cooking classes and newsletters promoting dietary targets of 5 vegetable servings, 3 fruit servings, 30 g of fiber, and 15%-20% energy from fat.
Trial: 2511698
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg nitroglycerine patch (70% drug release during the first 12 h)
Trial: 2511698
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg nitroglycerine patch (subchronic application)
Trial: 1103709
Drug: Orphenadrine/Paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orphenadrine/Paracetamol
Trial: 31368382
Drug: ICBTi (Internet-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICBTi (Internet-based cognitive behavioral therapy for insomnia)
Trial: 28606961
Drug: Disease activity-guided
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease activity-guided dose reduction (DR)
Trial: 24255998
Drug: Medication and
RxNorm normalized name: CVS Health Medication and Topical Refill Pouch KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication and medical management only (Control)
Trial: 21879261
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy with cisplatin and 5-fluorouracil (group 1)
Trial: 21879261
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy with cisplatin and 5-fluorouracil (group 2)
Trial: 8072048
Drug: Placebo acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo acupuncture treatment
Trial: 14756912
Drug: Lingzhi supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lingzhi supplementation (1.44 g Lingzhi/d; equivalent to 13.2 g fresh mushroom/d)
Trial: 7792309
Drug: Raloxifene (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (200 mg daily for 10 days)
Trial: 7792309
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg twice a day for 10 days)
Trial: 31607205
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg daily for 18 months
Trial: 12497780
Drug: Indapamide 1.5
RxNorm normalized name: indapamide 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide 1.5 mg daily
Trial: 21994128
Drug: Intraocular fluocinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraocular fluocinolone acetonide implant
Trial: 19292785
Drug: PUVA maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUVA maintenance treatment (irradiation twice weekly and then once weekly for 4 weeks)
Trial: 17716323
Drug: Synera patch
RxNorm normalized name: lidocaine / tetracaine Medicated Patch [Synera]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synera patch (lidocaine 70 mg and tetracaine 70 mg, 20-minute treatment)
Trial: 17716323
Drug: Placebo (20-minute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20-minute treatment)
Trial: 17716323
Drug: Synera patch
RxNorm normalized name: lidocaine / tetracaine Medicated Patch [Synera]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synera patch
Trial: 15244013
Drug: Cetraxate plus
RxNorm normalized name: Cetraxal
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetraxate plus clarithromycin and amoxicillin (CCA group)
Trial: 15244013
Drug: Pantoprazole plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole plus clarithromycin and amoxicillin (PCA group)
Trial: 9512152
Drug: Adjunctive subconjunctival
RxNorm normalized name: lincomycin
DrugBank: Lincomycin (DB01627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive subconjunctival mitomycin C
Trial: 9512152
Drug: No adjunctive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjunctive mitomycin C
Trial: 1729932
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg ketamine
Trial: 1729932
Drug: 6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/kg ketamine
Trial: 3838120
Drug: Vehicle of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle of the drug
Trial: 29937430
Drug: sotagliflozin 400
RxNorm normalized name: sotagliflozin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotagliflozin 400 mg
Trial: 25633683
Drug: empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: empagliflozin 25 mg